Tag Archive for: Ventures

Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

/in

Deal value up to US$1.05 billion Novo Holdings co-led Series A financing in Amolyt, supported additional financings and is Amolyt’s largest investor Acquisition validates Novo Holdings’ strategy to identify and invest long term in high quality European biotech companies Copenhagen, Denmark – Novo Holdings A/S, a leading international life sciences investor, today announced that its portfolio […]

Read more

Novo Holdings Venture Investments 2023 Newsletter: A record year advancing innovative therapies for patients

/in

18 new portfolio investments Five portfolio companies acquired $766 million invested and committed $600 million of cash exit proceeds San Francisco, Boston, London, and Copenhagen, Denmark, 5 March 2024 – The Novo Holdings Venture Investments team today published its review of 2023 – a record year advancing innovative therapies for patients. Read more…

Read more

The BioInnovation Institute welcomes eight new companies to its Venture Lab program

/in

COPENHAGEN, Denmark, August 31, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that eight new companies have entered its Venture Lab acceleration program for early-stage companies. The cohort is strategically aligned with BII’s focus on supporting innovative early-stage start-ups within human and planetary health.   […]

Read more

Novo Holdings Venture Investments team Newsletter

/in

The Novo Holdings Venture Investments team has published its 2023 newsletter today.   It is one of the largest and most active international life science venture investors with a track record of over 20 years investing in novel therapies.    For more information, please see Venture Investments 2023 Newsletter.    

Read more